HealthStream (NASDAQ:HSTM - Get Free Report) was upgraded by equities researchers at Craig Hallum to a "strong-buy" rating in a research report issued to clients and investors on Thursday, Zacks.com reports.
HSTM has been the subject of a number of other reports. StockNews.com lowered HealthStream from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th. Canaccord Genuity Group raised their price target on shares of HealthStream from $27.00 to $28.00 and gave the company a "hold" rating in a research report on Wednesday, July 24th. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $30.00.
Get Our Latest Research Report on HealthStream
HealthStream Price Performance
Shares of NASDAQ HSTM traded down $0.09 during mid-day trading on Thursday, reaching $28.84. 126,781 shares of the company's stock traded hands, compared to its average volume of 111,939. The business has a 50-day simple moving average of $28.61 and a 200 day simple moving average of $27.81. The stock has a market cap of $876.68 million, a P/E ratio of 49.72, a PEG ratio of 4.25 and a beta of 0.36. HealthStream has a 1-year low of $21.92 and a 1-year high of $31.15.
HealthStream (NASDAQ:HSTM - Get Free Report) last announced its quarterly earnings results on Monday, July 22nd. The technology company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02. The business had revenue of $71.56 million for the quarter, compared to analysts' expectations of $72.85 million. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The firm's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.13 EPS. Equities research analysts anticipate that HealthStream will post 0.56 earnings per share for the current fiscal year.
Insider Transactions at HealthStream
In related news, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the transaction, the director now owns 22,326 shares in the company, valued at approximately $636,960.78. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other HealthStream news, SVP Kevin P. O'hara sold 3,000 shares of the business's stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the sale, the senior vice president now directly owns 9,527 shares in the company, valued at $267,041.81. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Tate Deborah Taylor sold 1,400 shares of the company's stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the transaction, the director now directly owns 22,326 shares in the company, valued at $636,960.78. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 20.60% of the company's stock.
Institutional Investors Weigh In On HealthStream
Several large investors have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its holdings in HealthStream by 6.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 71,884 shares of the technology company's stock worth $2,073,000 after buying an additional 4,588 shares during the period. Ellsworth Advisors LLC lifted its position in shares of HealthStream by 5.1% during the third quarter. Ellsworth Advisors LLC now owns 20,035 shares of the technology company's stock worth $578,000 after acquiring an additional 972 shares in the last quarter. Creative Planning boosted its holdings in shares of HealthStream by 51.2% in the third quarter. Creative Planning now owns 15,844 shares of the technology company's stock worth $457,000 after acquiring an additional 5,368 shares during the period. Exchange Traded Concepts LLC grew its position in shares of HealthStream by 2.6% in the third quarter. Exchange Traded Concepts LLC now owns 59,322 shares of the technology company's stock valued at $1,711,000 after purchasing an additional 1,504 shares in the last quarter. Finally, Inspire Investing LLC raised its stake in shares of HealthStream by 54.8% during the 3rd quarter. Inspire Investing LLC now owns 44,072 shares of the technology company's stock valued at $1,271,000 after purchasing an additional 15,606 shares during the period. Hedge funds and other institutional investors own 69.58% of the company's stock.
HealthStream Company Profile
(
Get Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.